NCT01577589 - A 2-part Study to Assess Local Tolerability, Safety and Pharmacokinetics of Ceftaroline in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Healthy

Interventions

DRUG

600 mg ceftaroline fosamil in 50 ml infusion volume

IV infusion

DRUG

Placebo in 50 ml infusion volume

IV infusion

DRUG

600 ceftaroline fosamil in 250 ml infusion volume

IV infusion

DRUG

Placebo in 250 ml infusion volume

IV infusion

DRUG

600 mg ceftaroline in 100 ml infusion volume

IV infusion

DRUG

Placebo in 100 ml infusion volume

IV infusion

Trial Locations (1)

Research site, London